Interferon-gamma marks activated T lymphocytes in AIDS patients

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Human Immunodeficiency Virus type 1 (HIV-1) infection is a global health concern.
• Understanding the immune response to HIV-1 is crucial for developing effective treatments.
• T lymphocytes play a key role in cellular immunity.

Purpose of the Study:

• To investigate the presence and significance of interferon-gamma (IFN-gamma)-expressing T lymphocytes in HIV-1-infected individuals.
• To correlate IFN-gamma expression with disease progression and T-cell activation markers.

Main Methods:

• Flow cytometry was used to analyze lymphocytes expressing IFN-gamma on their surface.
• Patients included IV drug abusers infected with HIV-1.
• Comparison was made with healthy subjects, including HIV-1 seronegative IV drug abusers and blood donors.

Main Results:

• IFN-gamma-expressing T lymphocytes, predominantly CD8+ cells, were significantly higher in HIV-1 patients compared to healthy controls (p <= 0.001).
• The percentage of these cells increased with the progression of HIV-1 infection.
• Other T-cell activation markers (interleukin-2 receptor, transferrin receptor, HLA-DR) were also found in some HIV-1-infected subjects.

Conclusions:

• Activated CD8+ T cells expressing IFN-gamma are present in HIV-1-infected patients.
• These cells may be resistant to HIV-1 infection and contribute to the specific immune response against HIV-1.
• The findings suggest a potential role for these activated T cells in managing viral expression during HIV-1 infection.